Cited by

• The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle.

  Anupam R, Doueiri R, Green PL. Anupam R, et al. Front Microbiol. 2013 Sep 17;4:275. doi: 10.3389/fmicb.2013.00275. Front Microbiol. 2013. PMID: 24062732 Free PMC article. Review.
• Detection of HTLV-II-seropositive blood donors in South Vietnam but not in North Vietnam.

  Yamamoto S, Nakata S, Nakasone T, Chosa T, Song P, Duc DD, Hien B, Quang NX, Trinh TN, Ono T, et al. Yamamoto S, et al. Jpn J Cancer Res. 1994 Sep;85(9):875-8. doi: 10.1111/j.1349-7006.1994.tb02961.x. Jpn J Cancer Res. 1994. PMID: 7961112 Free PMC article.
• Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

  Lal RB, Heneine W, Rudolph DL, Present WB, Hofhienz D, Hartley TM, Khabbaz RF, Kaplan JE. Lal RB, et al. J Clin Microbiol. 1991 Oct;29(10):2253-8. doi: 10.1128/jcm.29.10.2253-2258.1991. J Clin Microbiol. 1991. PMID: 1939580 Free PMC article.
• Prevalence of HTLV infection in pregnant women in Spain.

  Machuca A, Tuset C, Soriano V, Caballero E, Aguilera A, Ortiz de Lejarazu R; HTLV Spanish Study Group. Machuca A, et al. Sex Transm Infect. 2000 Oct;76(5):366-70. doi: 10.1136/sti.76.5.366. Sex Transm Infect. 2000. PMID: 11141853 Free PMC article.
• Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.

  Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F. Bonis J, et al. J Clin Microbiol. 1993 Jun;31(6):1481-5. doi: 10.1128/jcm.31.6.1481-1485.1993. J Clin Microbiol. 1993. PMID: 8314990 Free PMC article.